After opioid maker Insys Therapeutics last week filed for bankruptcy protection five days after securing a $225 million settlement with the federal government, speculation has grown that other embattled opioid producers could take the same path. Insys makes the Subsys brand of the drug fentanyl, an opioid that is effective in easing pain for cancer patients. The justice department had accused Insys of using sham speaker programs to bribe doctors and their assistants to prescribe the drug and encourage addiction to it.
The justice department has pursued several other opioid manufacturers such as Purdue Pharma and drug distributors such as McKesson over charges that they helped fuel opioid addiction. However, as those companies face…
Read the full article at: https://knowledge.wharton.upenn.edu/article/opiod-settlements-is-insys-the-tip-of-the-iceberg/